FENC
Fennec Pharmaceuticals Inc
10.90$
+2.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | 0.0% | 5.6% | 5.9% | 6.7% | 8.4% | |
| – | – | – | – | – | – | 100.0% | 0.0% | 94.4% | 94.1% | 93.3% | 91.6% | |
| – | – | – | – | – | – | 3,002.9% | 2,930.0% | 230.0% | 0.3% | 0.6% | 0.6% | |
| – | – | – | – | – | – | 7,617.6% | 7,201.2% | 1,154.5% | 96.9% | 48.5% | 63.4% | |
| – | – | – | – | – | – | 10,620.6% | 10,131.2% | 1,575.7% | 155.5% | 88.1% | 105.8% | |
| – | – | – | – | – | – | -10,520.6% | -10,131.2% | -1,481.3% | -61.4% | 5.2% | -14.2% | |
| – | – | – | – | – | – | 5.3% | 74.1% | 63.7% | 16.0% | 8.6% | 4.7% | |
| – | – | – | – | – | – | -10,652.4% | -10,203.5% | -1,544.9% | -75.5% | -0.1% | -21.6% | |
| – | – | – | – | – | – | -110.0% | 64.7% | 73.3% | 0.0% | 0.8% | 0.2% | |
| – | – | – | – | – | – | -10,652.4% | -10,203.5% | -1,544.9% | -75.5% | -0.9% | -21.8% | |
| – | – | – | – | – | – | -10,647.1% | -10,129.4% | -1,471.5% | -58.2% | 10.1% | -16.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.